Oral administration of interferon-β suppresses experimental autoimmune uveoretinitis

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 240, Issue 4, 2002, Pages 314-321

  Suzuki, Jun ^a   Sakai, Jun Ichi ^a   Okada, Annabelle A ^b   Takada, Eiko ^c   Usui, Masahiko ^a   Mizuguchi, Junichiro ^c  

^a TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; CYTOKINE; FREUND ADJUVANT; GAMMA INTERFERON; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; PHOSPHATE; RECOMBINANT BETA INTERFERON; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELL PROLIFERATION; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOSE RESPONSE; DRUG MECHANISM; EMULSION; EYE INFLAMMATION; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; NATURAL KILLER CELL; NONHUMAN; OROPHARYNX; PRIORITY JOURNAL; RAT; SLIT LAMP; SPLEEN CELL; T LYMPHOCYTE; TIME; UVEORETINITIS;

ADMINISTRATION, ORAL; ANIMALS; AUTOIMMUNE DISEASES; EYE PROTEINS; FEMALE; FLOW CYTOMETRY; INTERFERON TYPE I, RECOMBINANT; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; RATS; RATS, INBRED LEW; RETINITIS; RETINOL-BINDING PROTEINS; SPLEEN; T-LYMPHOCYTES; UVEITIS;

EID: 0036939238     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-001-0425-z     Document Type: Article

References (38)

1. Arnason BGW (1996) Interferon beta in multiple sclerosis. Clin Immunol Immunopathol 81:1-11
2. Baron S, Tyring SK, Fleischmann WR, Coppenhaver DH, Niesel DW, Kimpel GR, Stanton GJ, Hughes TK (1991) The interferons: mechanisms of action and clinical applications. J Am Med Assoc 266:1375-1383
3. Barton K, Lightman S (1994) T lymphocyte effector mechanisms in the retina in posterior uveitis. Eye 8:60-65
4. Belardelli F, Gresser I (1996) The neglected role of type 1 interferon in the T-cell response: implications for its clinical use. Immunol Today 17:369-372
5. Borden EC (1992) Interferons-expanding therapeutic roles. N Engl J Med 326:1198-1205
6. Brod SA (1999) Autoimmunity is a type 1 interferon-deficiency syndrome corrected by ingested type 1 IFN via the GALT system. J Interferon Cytokine Res 19:841-852
7. Brod SA, Khan M (1996) Oral administration of IFN-β is superior to subcutaneous administration of IFN-β in the suppression of chronic relapsing experimental autoimmune encephalomyelitis. J Autoimmun 9:11-20
8. Brod SA, Khan M, Kerman RH, Pappolla M (1995) Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis. J Neuroimmunol 58:61-69
9. Brod SA, Scott M, Burns DK, Phillips JT (1995) Modification of acute experimental autoimmune encephalomyelitis in the Lewis rat by oral administration of type 1 interferons. J Interferon Cytokine Res 15:115-122
10. Brod SA, Kerman RH, Nelson LD, Marshall GD Jr, Henninger EM, Khan M, Jin R, Wolinsky JS (1997) Ingested IFN-β has biological effects in human with relapsing-remitting multiple sclerosis. Mult Scler 3:1-7
11. Brod SA, Malone M, Darcan S, Papolla M, Nelson L (1998) Ingested interferon suppresses Type 1 diabetes in non-obese diabetic mice. Diabetologia 41:1227-1232
12. Caspi RR, Roberg FG, Chann CC, Wiggert B, Charder GJ, Rozenszajn LA, Lando Z, Nussenblatt RB (1988) A new model of autoinumme disease: experimental autoimunne uveoretinitis induced in mice with two different retinal antigens. J Immunol 140:1490-1495
13. Demiroglu H, Ozcebe OI, Barista I, Dundar S, Eldem B (2000) Interferon alpha-2b, colchicine, and benzathine penicillin versus colchicine and benzathine penicillin in Behçet's disease: a randomised trial. Lancet 355:605-9
14. Eid P, Meritet IF, Maury C, Lasfar A, Weill D, Tovey MG (1999) Oromucosal interferon therapy: pharmacokinetics and pharmacodynamics. J Interferon Cytokine Res 19:157-169
15. Falcon M, Yeung B, Tucker L, Rodriguez E, Sarvetnick N (1999) A defect in interleukin 12-induced activation and interferon secretion of peripheral natural killer T cells in non-obese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus. J Exp Med 7:963-972
16. Fleischmann WR, Koren S, Fleischmann CM (1992) Orally administered interferons exert their white blood cell suppressive effect via a novel mechanism. Proc Soc Exp Biol Med 201:199-207
17. Georgiades JA, Fleischmann WR Jr (1996) Oral application of cytokines. Biotherapy 8:205-212
18. Kotter I, Eckstein AK, Stubiger N, Zierhut M (1998) Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study. Br J Ophthalmol 82:488-494
19. Matsuda S, Utsumi J, Kawano G (1986) Purification and characterization of recombinant mouse interferonβ. J Interferon Res 6:519-526
20. Matsumoto Y, Kohyama K, Aikawa Y, Shin T, Kawazoe Y, Suzuki Y, Tanuma N (1998) Role of natural killer cells and TCR T cells in acute autoimmune encephalomyelitis. Eur J Immunol 28:1681-1688
21. Mieza MA, Itoh T, Cui JQ, Makino Y, Kawano T, Tsuchida K, Koike T, Shirai T, Yagita H, Matsuzawa A, Koseki H, Taniguchi M (1996) Selective reduction of V alpha 14+ NKT cells associated with disease development in autoimmune-prone mice. J Immunol 156:4035-4040
22. Nussenblatt RB, Kuwabara RT, Monasterio FM, Wacker WB (1981) S-antigen uveitis in primates: a new model for human disease. Arch Opthalmol 99:1090-1092
23. O'Duffy JD, Calamia K, Cohen S, Goronzy JJ, Herman D, Jorizzo J, Weyand C, Matteson E (1998) Interferon-alpha treatment of Behçet's disease. J Rheumatol 25:1938-44
24. Okada AA, Keino H, Fukai T, Sakai J, Usui M, Mizuguchi J (1998) Effect of type 1 interferon on experimental autoimmune uveoretinitis in rats. Ocular Inflamm, Immunol 6:215-226
25. Okada AA, Keino H, Suzuki J, Sakai J, Usui M, Mizuguchi J (1998) Kinetics of intraocular cytokines in the suppression of experimental autoimmune uveoretinitis by type 1 IFN. Int Immunol 10:1917-1922
26. Pauleseu L, Corradeschi F, Nicoletti C, Bocci V (1988) Oral administration of human recombinant interferon-2 in rats. Int J Pharmaceutics 46:199-202
27. Redmond TM, Wiggert B, Robey FA, Nguyen NY, Lewis MS, Lee L, Chader GJ (1985) Isolation and characterization of monkey interphotoreceptor retinoid-binding protein, a unique extracellular matrix component of the retina. Biochemistry 24:787-793
28. Rollwagen FM, Bagar S (1996) Oral cytokine administration. Immunol Today 17:548-550
29. Saoudi A, Kuhn J, Huygen K, de Kozak Y, Velu T, Goldman M, Druet P, Bellon B (1993) TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur J Immunol 23:3096-3103
30. Sen GC, Lengyel P (1992) The interferon system. A bird's eye view of its biochemistry. J Biol Chem 267:5017-20
31. Ship JA, Fox PC, Michalek JE, Cummins MJ, Richards AB (1999) Treatment of primary Sjögren's syndrome with low-dose natural humann interferon administered by the oral mucosal route: a phase II clinical trial. J Interferon Cytokine Res 19:943-951
32. Smeltz RB, Wolf NA, Swanborg H (1999) Inhibition of autoimmune T cell responses in the DA rat by bone marrow-derived NK cells in vitro: implications for autoinummity. J Immunol 163:1390-1397
33. Takayama S, Iwaki K, Nishida Y, Tanaka M, Fujii M, Ohashi K, Ikeda M, Kurimoto M (1999) Effect of oral administration of interferon-α on antibody production in mice with induced tolerance. J Interferon Cytokine Res 19:895-900
34. Wildner G, Hunig T, Thurau SR (1996) Orally induced, peptide-specific γδ TCR+ cells suppress experimental autoimmune uveitis. Eur J Immunol 26:2140-2148
35. ser. J Interferon Cytokine Res 12:411-413
36. Yoshino S (1995) The preventive effect of oral administration of type 1 interferon on collagen-induced arthritis in rats. Exp Mol Pathol 62:123-130
37. Yotsukura J, Huang H, Singh AK, Shichi H (1997) Regulatory cells generated by testicular tolerization to retinal S-antigen: possible involvement of IL-4, IL-10, and TGF-β in the suppression of experimental autoimmune uveoretinitis. Cell Immunol.182:89-98
38. Zhang B, Yamamura T, Kondo T, Fujiwara M, Tabira T (1997) Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 186:1677-87